Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Inamed To Finalize $142 Mil. Collagen Aesthetics Acquisition By Oct. 1

This article was originally published in The Gray Sheet

Executive Summary

Inamed is looking to build a $225 mil. global plastic and aesthetic surgery device business through the acquisition of Palo Alto, California-based Collagen Aesthetics.

You may also be interested in...



Inamed's 2.5 Mil. Share Secondary Offering Expected To Net $60 Mil.

Proceeds from Inamed's secondary 2.5 mil. share stock offering will go toward significantly reducing the $155 mil. in outstanding debt under the company's bridge loan facility.

Inamed's 2.5 Mil. Share Secondary Offering Expected To Net $60 Mil.

Proceeds from Inamed's secondary 2.5 mil. share stock offering will go toward significantly reducing the $155 mil. in outstanding debt under the company's bridge loan facility.

Inamed's Lap Band Poised To Squeeze Out U.S. Morbid Obesity Market In 2000

Introduction of the Lap Band adjustable gastric banding system could increase Inamed obesity product sales up to four-fold by 2002, Inamed President Ilan Reich told investors attending the Bear Stearns Healthcare Conference Sept. 17 in New York City.

Related Content

UsernamePublicRestriction

Register

OM013626

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel